Multihance Interactions
There are 53 drugs known to interact with Multihance (gadobenate dimeglumine), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 53 are moderate.
- View all 53 medications that may interact with Multihance
- View Multihance alcohol/food interactions (1)
- View Multihance disease interactions (5)
Most frequently checked interactions
View interaction reports for Multihance (gadobenate dimeglumine) and the medicines listed below.
- acetaminophen
- adenosine
- Advair Diskus (fluticasone / salmeterol)
- Afrin NoDrip Sinus (oxymetazoline nasal)
- Alaway (ketotifen ophthalmic)
- Aleve (naproxen)
- alfentanil
- allopurinol
- alpha-lipoic acid
- alprazolam
- alvimopan
- amiodarone
- amlodipine
- Arthrotec (diclofenac / misoprostol)
- ashwaganda
- Aspirin Low Strength (aspirin)
- atenolol
- Atrovent (ipratropium)
- Augmentin (amoxicillin / clavulanate)
- cetirizine
- gabapentin
- levothyroxine
- Lexapro (escitalopram)
- melatonin
- metformin
- MiraLAX (polyethylene glycol 3350)
- Mucinex (guaifenesin)
- omeprazole
- rosuvastatin
- tramadol
Multihance alcohol/food interactions
There is 1 alcohol/food interaction with Multihance (gadobenate dimeglumine).
Multihance disease interactions
There are 5 disease interactions with Multihance (gadobenate dimeglumine) which include:
More about Multihance (gadobenate dimeglumine)
- Multihance consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: magnetic resonance imaging contrast media
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.